A multi-center pragmatic, randomized, feasibility trial comparing standard of care schedules of filgrastim administration for primary febrile neutropenia prophylaxis in early-stage breast cancer.
Mohammed F K IbrahimJohn HiltonSasha MazzarelloDean FergussonBrian HuttonAndrew RobinsonNadia CalifarettiTina HsuStan GertlerMihaela MatesCarol StoberLisa VandermeerRanjeeta MallickMark ClemonsPublished in: Breast cancer research and treatment (2017)
ClinicalTrials.gov: NCT02428114.
Keyphrases
- phase iii
- early stage
- chemotherapy induced
- phase ii
- study protocol
- open label
- double blind
- placebo controlled
- clinical trial
- healthcare
- palliative care
- quality improvement
- randomized controlled trial
- sentinel lymph node
- urinary tract infection
- pain management
- affordable care act
- squamous cell carcinoma
- young adults
- health insurance
- lymph node